These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 60267)
1. Immune response in fulminant viral hepatitis, type B. Tabor E; Gerety RJ; Hoofnagle JH; Barker LF Gastroenterology; 1976 Oct; 71(4):635-40. PubMed ID: 60267 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990 [TBL] [Abstract][Full Text] [Related]
3. Detection of e antigen and antibody: correlations with hapatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections. Trepo CG; Magnius LO; Schaefer RA; Prince AM Gastroenterology; 1976 Nov; 71(5):804-8. PubMed ID: 61146 [TBL] [Abstract][Full Text] [Related]
4. Correlation between titer of antibody to hepatitis B core antigen and presence of viral antigens in the liver. Kojima M; Udo K; Takahashi Y; Yoshizawa H; Tsuda F; Itoh Y; Miyakawa Y; Mayumi M Gastroenterology; 1977 Oct; 73(4 Pt 1):664-7. PubMed ID: 330306 [TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Perrillo RP; Chau KH; Overby LR; Decker RH Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B core antigen and antibody. Hoofnagle JH; Gerety RJ; Barker LF Dev Biol Stand; 1975; 30():175-85. PubMed ID: 1204955 [TBL] [Abstract][Full Text] [Related]
7. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033 [TBL] [Abstract][Full Text] [Related]
10. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis]. Dentico P; Pastore G; Buongiorno R; Angarano G; Lapedota E; Schiraldi O Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1141-6. PubMed ID: 317942 [TBL] [Abstract][Full Text] [Related]
11. [Antibodies against hepatitis B (surface) antigen in patients with hepatitis and other groups of epidemiologic interest (author's transl)]. Lange W; Apodaca J; Köhler H Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):199-212. PubMed ID: 1179881 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients. Okuda H; Obata H; Motoike Y; Hisamitsu T Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615 [TBL] [Abstract][Full Text] [Related]
13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection. Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883 [TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis type B: propects for active immunization. Krugman S Dev Biol Stand; 1975; 30():363-7. PubMed ID: 1204971 [TBL] [Abstract][Full Text] [Related]
15. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. Han Y; Tang Q; Zhu W; Zhang X; You L J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435 [TBL] [Abstract][Full Text] [Related]
16. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy. Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma. Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625 [TBL] [Abstract][Full Text] [Related]
18. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases]. Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780 [TBL] [Abstract][Full Text] [Related]
19. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination. Tsuda F; Takahashi T; Takahashi K; Miyakawa Y; Mayumi M J Immunol; 1975 Sep; 115(3):834-8. PubMed ID: 1171142 [TBL] [Abstract][Full Text] [Related]
20. Induction of antibody to the "y" determinant of HBsAg in a chimpanzee carrier of HBsAg subtype "adw". Tabor E; Gerety RJ; Smallwood LA; Barker LF J Immunol; 1976 Nov; 117(5 Pt.2):2038-40. PubMed ID: 62804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]